Latest 10-Q quarterly reports
OID
Farmers and Merchants Bancshares, Inc. announced its financial results for the second quarter ended June 30, 2026, showcasing increased net income and improved net interest income.
NASDAQ
CPS Technologies Corp. reported a 3% increase in revenue for the second quarter of 2026, reaching $8.3 million, but incurred a net loss of $256,432 for the first six months of the year.
NASDAQ
Texas Community Bancshares, Inc. announced a significant increase in net income and net interest income for the second quarter of 2026, driven by loan growth and improved margins.
NYSE
Flowco Holdings Inc. announced significant revenue increases in its second quarter, driven by the Valiant acquisition and expanded rental fleet operations.
NASDAQ
Lake Shore Bancorp, Inc. announced a significant increase in net income and net interest income for the second quarter of 2026, driven by improved interest margins and asset growth.
NASDAQ
Harvard Bioscience, Inc. announced its second quarter 2026 financial results, showing an 11.1% increase in revenue to $22.7 million but a net loss of $2.9 million.
NASDAQ
Odyssey Marine Exploration, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, detailing significant net losses, a substantial working capital deficit, and ongoing going concern uncertainties, while also outlining progress on its proposed merger with American Ocean Minerals.
Terrestrial Energy Inc. filed its Q2 2026 Form 10-Q, detailing increased operating expenses and net losses, alongside progress in regulatory approvals and strategic collaborations.
OTC.Pink
SYBX
Synlogic, INCSynlogic reports a net loss for the quarter and six months ended June 30, 2026, while advancing a significant merger with Caldera Therapeutics.
AMEX
Hyliion Holdings Corp. reports increased R&D revenue driven by government contracts, advances KARNO Power Module development, and outlines plans for a $100 million at-the-market offering.
RMBL
Rumbleon, INCRideNow Group, Inc. (RDNW) announced its Q2 2026 results, showcasing a significant turnaround in profitability driven by strong powersports segment performance and a reduction in operating expenses.
NASDAQ
STIM
Neuronetics, INCNeuronetics reported increased revenue in Q2 2026 driven by its Greenbrook segment, but faces substantial doubt regarding its ability to continue as a going concern due to projected covenant non-compliance.
NYSE
Amentum Holdings, Inc. reported a significant increase in net income attributable to common shareholders for the nine months ended July 3, 2026, driven by operational efficiencies and a robust backlog.
NASDAQ
Silicon Laboratories Inc. (SLAB) reported increased revenues for the quarter ended July 4, 2026, but also a net loss, with significant merger-related costs impacting operating expenses.
NYSE
ESS Tech, Inc. reported a dramatic 97% decrease in revenue for the three months ended June 30, 2026, alongside significant operating losses and a stark warning about its ability to continue as a going concern.
NASDAQ
Mobile Infrastructure Corporation's Q2 2026 10-Q filing reveals continued net losses and significant debt, raising substantial doubt about its ability to continue as a going concern.
NASDAQ
CDXS
Codexis, INCCodexis, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, reporting an increase in product revenue but a continued net loss, alongside a significant decrease in cash and cash equivalents.
NASDAQ
ATAI
Ataibeckley INCAtaiBeckley Inc. has entered into a merger agreement with Eli Lilly and Company for an acquisition valued at $6.75 per share plus contingent value rights, while reporting Q2 2026 results with increased R&D expenses and continued net losses.
NASDAQ
SNAL
Snail, INCSnail Inc. filed its Form 10-Q for the quarter ended June 30, 2026, detailing a net loss of $3.04 million and ongoing challenges with Nasdaq listing requirements.
NASDAQ
Inhibikase Therapeutics, Inc. (IKT) filed its Q2 2026 10-Q, detailing increased R&D expenses, a substantial net loss of $19.6 million for the quarter, and highlighting the critical need for future capital raises to sustain operations.
NYSE
Waters Corporation's Q2 2026 10-Q filing reveals a significant net loss and increased debt, largely due to the recent BDS Business Acquisition, despite substantial revenue growth.
NASDAQ
Tandy Leather Factory, Inc. (TLF) reported a 1.5% increase in net sales for Q2 2026, driven by sales campaigns and improved product mix, alongside a significant 10.6% rise in gross profit due to pricing adjustments.
NASDAQ
Highview Merger Corp. reports on its financial condition and operational status for the quarter ended June 30, 2026, highlighting interest income and ongoing efforts to identify a business combination target.
NYSE
ARMK
AramarkAramark's Q3 2026 filing shows a significant increase in revenue and operating income, driven by strong performance in both domestic and international segments, despite some cost pressures.
NASDAQ
Factorial Energy Inc. filed its Form 10-Q for the quarter ended June 30, 2026, detailing continued net losses and operational expenses as it advances its solid-state battery technology.
NASDAQ
Autolus Therapeutics plc announced significant revenue growth in the second quarter of 2026, primarily driven by increased sales of its AUCATZYL therapy in the US and UK.
NASDAQ
Lenz Therapeutics announced its second-quarter 2026 financial results, highlighting initial product sales for VIZZ but also a substantial increase in operating expenses and continued net losses.
NASDAQ
Fold Holdings, Inc. reported a 26% year-over-year revenue decrease for Q2 2026, driven by a downturn in digital asset markets, alongside significant operating losses and a material weakness in internal controls.
NASDAQ
TILE
Interface INCInterface Inc. announced a 5.4% increase in Q2 2026 net sales to $395.7 million and a significant rise in net income to $51.4 million, driven by higher demand and improved margins.
OTC.Pink
EBRCZ
Ebr Systems, INCEBR Systems, Inc. reported increased net sales for Q2 2026, but also disclosed substantial doubt about its ability to continue as a going concern, despite FDA approval of its WiSE CRT System.